Report #2850864

Received Jul 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: CO
Recovered: Recovered
Vaccinated: Jul 1, 2025
Onset: Jul 2, 2025
Days to onset: 1
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
COVID19	COVID19 (COVID19 (PFIZER-BIONTECH))	PFIZER\BIONTECH	1	—	—
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	—	—

Symptoms (1)

Vaccination site erythema

Symptom narrative

Redness extending around the shot but not in the area of the spot/This lasted for about 1.5 weeks after the shot; This is a spontaneous report received from an Other HCP from a sales representative. An adult female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 01Jul2025 as dose 1, single (Batch/Lot number: unknown), in arm for covid-19 immunisation; varicella zoster vaccine rge (cho) (SHINGRIX), on 01Jul2025 as dose 1, single. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset 02Jul2025, outcome "recovered", described as "Redness extending around the shot but not in the area of the spot/This lasted for about 1.5 weeks after the shot". Therapeutic measures were not taken as a result of vaccination site erythema. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.